liver cancer
Conditions
Interventions
Experiment group:SBRT followed by apatinib
Control:apatinib
Sponsors
Sichuan Provincial People's Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Subject's aged =18 years old; 2. Patients with locally advanced liver cancer who are unwilling or unwilling to undergo liver transplantation, hepatectomy, arterial chemoembolization and radiofrequency therapy must be diagnosed on the basis of biopsy or typical imaging findings (previous history of cirrhosis or chronic hepatitis B and hepatitis C), strict Patients with primary locally advanced HCC (single lesion diameter <6 cm) who meet the clinical diagnostic criteria for primary diagnosis and treatment of primary liver cancer (2011 version) or pathologically diagnosed or cytologically untreated without systemic chemotherapy and molecular targets To treatment; 3. Into the group did not occur within 2 months before the bleeding; 4. Sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. can not tolerate radiotherapy; 3. has the contraindication of apatinib (to the specification).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TTP;OS; | — |
Countries
China
Contacts
Public ContactZeng Ming
Sichuan Provincial People's Hospital
Outcome results
None listed